These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6060632)

  • 81. [Therapy of cerebral ictus by continuous intravenous perfusion of bamethan].
    Piovella C; Galli C; Torti G
    Clin Ter; 1972 Feb; 60(3):217-28. PubMed ID: 4146838
    [No Abstract]   [Full Text] [Related]  

  • 82. [Treatment of arterial hypertension in patients with cerebrovascular insufficiency].
    Strazzullo P; Ferrara LA; Lamenza F; Tudisca G; De Cristofaro M
    Acta Neurol Quad (Napoli); 1980; 41():82-5. PubMed ID: 7293742
    [No Abstract]   [Full Text] [Related]  

  • 83. [What is assured in drug therapy of cerebrovascular circulation disorders?].
    Gottstein U
    Med Klin; 1973 Jul; 68(29):947-51. PubMed ID: 4579835
    [No Abstract]   [Full Text] [Related]  

  • 84. Proxazole in cerebrovascular insufficiency. A controlled clinical trial.
    Esposito G; De Gregorio M
    Arzneimittelforschung; 1974 Oct; 24(10):1692-6. PubMed ID: 4611436
    [No Abstract]   [Full Text] [Related]  

  • 85. [Therapeutic activity of nicergoline in cerebrovascular syndromes].
    Toni E
    Minerva Med; 1973 Nov; 64(84):4466-73. PubMed ID: 4771472
    [No Abstract]   [Full Text] [Related]  

  • 86. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine].
    Cosmi F; Caresia L; Panebianco G
    Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528
    [No Abstract]   [Full Text] [Related]  

  • 87. [On the therapy of cerebral and peripheral circulatory disorders in general practice].
    Risse S
    Med Welt; 1967 Jul; 28():1659-62. PubMed ID: 5612140
    [No Abstract]   [Full Text] [Related]  

  • 88. Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy.
    Man'kovsky NB; Minz AY
    Gerontology; 1988; 34(1-2):75-81. PubMed ID: 3384341
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Treatment and prevention of cerebral arterial disorders in aged and of their consequences. Rheoencephalographic examinations].
    Albot G; Goutmer B; Treps J
    Therapeutique; 1971; 47(6):579-84. PubMed ID: 5571174
    [No Abstract]   [Full Text] [Related]  

  • 90. [Effect of a vasoactive agent on brain circulation].
    Haragus S; Muresan IG; Schneider E
    Wien Med Wochenschr; 1972 Mar; 122(11):152-7. PubMed ID: 5047084
    [No Abstract]   [Full Text] [Related]  

  • 91. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
    Mémin Y; Najean Hueber E
    Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
    [No Abstract]   [Full Text] [Related]  

  • 92. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 93. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 94. [Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure].
    Ishchenko MM; Shkrobot SI
    Vrach Delo; 1984 Jul; (7):68-70. PubMed ID: 6475025
    [No Abstract]   [Full Text] [Related]  

  • 95. [Effects of flunarizine on chronic cerebrovascular insufficiency: experience of a geriatric department].
    Ronchini P; D'Ambrosio E; Anesi E; Pellicioni P
    G Clin Med; 1982 Feb; 63(2):131-9. PubMed ID: 7106462
    [No Abstract]   [Full Text] [Related]  

  • 96. [The value of Sureptil in O.R.L].
    Mounier-Kuhn P; Jacquemard C; Haguenauer JP; Bouchayer M
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Oct; 18(8):551-6. PubMed ID: 4249534
    [No Abstract]   [Full Text] [Related]  

  • 97. [Rheoencephalographic studies with Ustimon (hexobendine)].
    Mayr F; Geyer N
    Wien Klin Wochenschr; 1966 Apr; 78(13):232-5. PubMed ID: 5983529
    [No Abstract]   [Full Text] [Related]  

  • 98. [A delayed-action therapeutic agent in chronic cerebral circulatory insufficiencies].
    Boudouresques J; Papy JJ; Daniel F
    Therapeutique; 1970 Oct; 46(8):789-92. PubMed ID: 5458910
    [No Abstract]   [Full Text] [Related]  

  • 99. [Treatment of cerebrovascular disorders. 5. Selection of therapeutic agents to improve cerebral circulation and metabolism].
    Togi H
    Nihon Naika Gakkai Zasshi; 1991 Apr; 80(4):570-7. PubMed ID: 2061635
    [No Abstract]   [Full Text] [Related]  

  • 100. [1035 M.D. in neurologic accidents of vascular origin].
    Fénelon J
    J Med Bord; 1967 Dec; 144(12):1898-902. PubMed ID: 5622080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.